Fingerprint
Dive into the research topics of 'Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer: a well-tolerated, active and convenient regimen'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically